Psychiatry
For psychiatric practices managing insomnia alongside other conditions: a non-sedating option with objective evidence of increased deep and REM sleep, for patients where sedative burden is a concern.
Why sleep architecture matters
Most sleep aids are judged on onset and continuity. Defined Sleep's trial measured the objectively recorded proportion of deep (slow-wave) and REM sleep. In the FDA-registered Phase 2 crossover trial, participants with severe insomnia experienced increased deep and REM sleep and decreased light sleep, measured nightly by validated wearable actigraphy.
Use cases in psychiatric practice
- Psychiatric patients with comorbid insomnia where sedative burden is a concern
- Patients who decline or wish to discontinue prescription hypnotics
- Patients who want to avoid THC: Defined Sleep contains 0.0% THC, verified by third-party testing of every lot
“Insomnia is a common symptom associated with many psychiatric conditions, including anxiety. I recommend Defined Sleep to my psychiatry patients because it is a safe and effective alternative to stronger sleep medicines.”
“As a practitioner focused on cognitive health, Defined Sleep is the first supplement I've seen with rigorous clinical backing for actual sleep architecture improvements.”
Bring clinically validated restorative sleep to your patients
Register in under a minute for patient literature, practice ordering, and practice discount codes.
Register as an HCP Ask our science & medical teamPublished study (JCSM) · ClinicalTrials.gov NCT05233761 · Ask our science & medical team
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.